The use of complementary and alternative medicine is widespread and popular with the lay public. Although prevalence of use varies among specific patient populations, complementary and alternative medicine, in particular herbal remedies, are widely marketed and used by orthopaedic patients. Herbal supplements can have a negative impact on the perioperative period and may interact with conventional medicines used to manage chronic conditions. Physician-patient communication often does not include the subject of alternative medicines, leading to underreporting of use. Orthopaedic surgeons should adopt methods to routinely elicit from their patients the use of complementary and alternative medicine and should monitor and counsel patients on potential side effects and drug-herb interactions. Preoperative instructions should include cessation of the use of herbal supplements.
T he use of complementary and alternative medicine (CAM) in the United States is widespread. The prevalence of use increased exponentially from 1990 to 1997 but since then appears to have stabilized, at approximately one third of the US population. 1, 2 Specific subpopulations of patients exhibit greater use. Older patients (≥65 years) and those with chronic pain or chronic conditions associated with pain have the greatest prevalence, ranging from 52% to 64%. 3, 4 Among ambulatory surgical patients, prevalence of CAM use ranged from 27% to 43% within 2 weeks of surgery. 5, 6 Among orthopaedic patients, trends are similar, with a prevalence ranging from 35% to as high as 70%. 7, 8 The associated cost is large: an estimated $33.9 billion was spent on CAM products and services in 2007. 9 Many forms of CAM exist, including herbal, nutritional, and megavitamin supplements; physical manipulation (eg, massage, chiropractic); and other modalities, (eg, aromatherapy, self-help organizations, folk and ayurvedic remedies, hypnosis, energy healing). Herbal supplementation is perhaps the most common: an estimated 38 million US adults use herbs. 2 Unlike conventional medicines, herbal remedies are not regulated by governmental agencies such as the FDA. The Dietary and Supplement Health and Education Act of 1994 classified herbal remedies as dietary supplements, which rendered them exempt from the safety and efficacy regulations required of prescription and over-the-counter medications. As a result, the safety and efficacy of individual herbal remedies have not David T. Rispler, MD Julie Sara, MD been thoroughly evaluated in large clinical trials. Furthermore, limited information is available in the medical literature on drug-herb interactions. Compounding these issues, herbal remedies in particular are marketed to consumers with labels such as "natural" and "homeopathic," which consumers may interpret as being synonymous with "safe." This attitude may contribute to the widespread practice of taking prescription medications simultaneously with herbal medicines, which is practiced by approximately one in five prescription users (approximately 15 million adults). 2 In contrast to the assumption that these remedies are safe, a recent study reported the deaths of four children that resulted from the use of alternative medicine used in place of conventional medicines. 10 Given the widespread use of CAM, orthopaedic physicians must educate themselves regarding the potential side effects, drug interactions, and perioperative complications of herbal remedy use. It is also necessary to develop standard techniques for eliciting from patients their history of alternative therapy use.
Eliciting CAM Use by Patients
Underreporting of CAM use is a well-documented phenomenon. In one study, 64% of patients with osteoarthritis (OA) in an orthopaedic clinic underreported CAM use, and a surgical population with OA underreported its use by 40.6%. 8 Nondisclosure of CAM use creates the potential for drug-herb interaction and risk.
One of the main reasons that patients do not disclose the use of CAM is that they may not believe it is important information to convey to the physician. 7 This attitude may be a reflection of marketing strategies, which tout supplements as natural remedies, in turn creating the perception that no side effects are associated with herbal supplement use. 7 However, at least one study has documented that physicians may choose not to record the use of CAM when patients report it. 3 Other reasons for nondisclosure include patient perception of prejudice against their use by physicians and physician ignorance of herbal medications.
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Because of the prevalence of the use of CAM, it is important that the use of these supplements be documented in all patients. However, routine patient histories often do not elicit CAM use. 3, 8 Physicians must develop and implement techniques to monitor CAM use in their patients. Unbiased, specific questions regarding CAM use, with checklists, increases patient reporting of herbal supplement use. 7, 8 Such lists may prompt patients to name nonprescription medications that they use even if the medications are not present on the list. Patients should be counseled to fully disclose all medications-prescription, over-thecounter, and herbal remedies. Finally, continual monitoring, in the form of an annual update of this information, helps in the assessment of new herbal medications that patients may begin taking.
Counseling Patients Perioperatively
The perioperative period presents a unique challenge in monitoring CAM use because of the physiologic alterations associated with surgery as well as with the drugs administered during and after surgery. CAM use may contribute to increased blood loss and the potential need for blood transfusions. As mentioned, the problem for surgeons is a pervasive one; the prevalence of herbal supplement use perioperatively was reported in one study to be 27%. 5 Because of the absence of regulatory oversight, no comprehensive research is available on the physiologic effects of many herbal remedies. Neither the half-lives of the active ingredient or ingredients of herbal remedies nor the pharmacokinetic and pharmacodynamic properties are well established. Adding to this uncertainty, formulations often are not standardized from product to product. As a result of this lack of data, no standardized timetables exist for cessation of herbal medications before surgery. This is in contrast with conventional medicines, use of which is stopped before surgery on a timetable that reflects the half-life of these drugs and their potential for perioperative complications. For example, the half-life of ibuprofen is 1.6 to 1.9 hours, and it is recommended that this drug be discontinued 1 to 2 days before surgery to reduce the risk of bleeding. 12 Likewise, naproxen, with a half-life of 15 hours, is discontinued 3 days before surgery. By contrast, aspirin, which irreversibly inhibits platelet activity, must be discontinued 7 to 10 days before surgery, thereby allowing sufficient time for platelet regeneration.
In general, given the lack of information on the metabolism of herbal remedies, it is prudent to counsel patients to cease taking herbal remedies at least 1 week before surgery because of the possibility of producing negative outcomes. 13 In regard to herbal remedies with long or unknown half-lives, cessation 2 weeks before surgery is warranted. Herbal supplementation should be avoided in the postsurgical period until the wound heals and the risk of hematoma and subsequent infection has subsided, usually 1 to 2 weeks, de-pending on the magnitude of the surgery.
Conservatively, any herbal remedy with the potential to interact with anticoagulant therapy should not be taken within 2 weeks of surgery. Additionally, such herbs should not be used until anticoagulants are discontinued. Depending on the anticoagulant, this delay may be for 2 to 4 weeks. Finally, in patients whose CAM use stems from cultural beliefs or lifestyle, communication between the primary care physician, anesthesiologist and naturopath may be warranted.
Common Supplements and Potential Side Effects
The popularity of herbal supplements changes over time, but use of the herbs discussed here has been demonstrated as recently as 2009 14 (Table 1) . Table 2 provides a summary of the marketed uses, the potential side effects and drug interactions, and the perioperative and postoperative recommendations for the 12 popular herbal supplements discussed below.
The assessment of risks associated with herbal use is complicated by several factors, but the most important is the lack of data from large, well-designed placebo-controlled clinical trials. The incidence and severity of adverse events associated with herbal supplement use is not studied, and postmarketing surveillance information is not cohesively monitored by the FDA or any other governmental agency. 16, 17 Adverse effects and drug-herb interaction have been reported in the literature, mainly as case reports. 18 Such case reports are helpful, but often they do not establish a cause-and-effect relationship between herbal remedy and side effect. In general, herbal remedies can potentiate the side effects or change the efficacy of conventional medicines by interfering with the metabolism or bioavailability of these medicines via cytochrome P450 (CYP) enzymes. 3, 7, 19, 20 Further, herbs can act synergistically or additively to change the efficacy of a drug. The recommendations below are based on such resources and represent our current understanding of these herbs.
Cranberry (Vaccinium macrocarpon) is mainly used to treat or prevent urinary tract infections (UTIs) by preventing adherence of harmful bacteria to the urinary tract epithelium. Several clinical trials support the assertion that cranberry products reduce the number of UTIs in women with recurrent infections; however, the dropout rates in these trials were high, and no reliable evidence exists that cranberry can treat UTIs. 21 Anecdotal evidence that cranberry juice interacts with warfarin to potentiate anticoagulation was tested in a clinical trial of warfarin users; no pharmacokinetic effect on warfarin was observed. 22 Side effects include mild diarrhea. Cranberry can potentiate kidney stones in at-risk patients.
Echinacea (Echinacea purpurea, E angustifolia, E pallida) is used as prophylactic treatment for upper respiratory tract infections. Research shows that echinacea stimulates the immune system. 13, 17, 23 However, longterm use of echinacea may be immunosuppressive and increase the risk of perioperative opportunistic infec- tion; thus, concomitant use with immunosuppressive medicines is discouraged. 17 For this reason, it is prudent for patients to stop taking echinacea 2 weeks before surgery and resume its use no earlier than 2 weeks after surgery.
Feverfew (Tanacetum parthenium), a popular herbal remedy used for the prevention of migraine headaches, functions by inhibiting serotonin release. Feverfew has shown some benefit in several clinical trials, although the largest trial to date did not show any benefit. 24 Feverfew inhibits collagen-induced platelet aggregation. Thus, persons taking blood thinners (eg, warfarin, enoxaparin, ticlopidine, clopidogrel, aspirin) should avoid taking feverfew. Acute withdrawal symptoms after cessation may occur, including rebound headaches. Postoperatively, feverfew should not be resumed until after anticoagulant therapy.
Garlic (Allium sativum) is used to reverse hypercholesterolemia and to decrease blood pressure. The mechanism of action is unknown. Data from clinical studies are inconclusive; garlic shows only very modest or no improvements in total cholesterol. 23 Research has shown that garlic inhibits thromboxane production and platelet aggregation in a dosedependent manner. It also may potentiate postoperative bleeding by interaction with other platelet inhibitors (eg, prostacyclin, forskolin, in- domethacin, dipyridamole). 13 Garlic has a short half-life; it should be stopped 1 week before surgery and should not be resumed postoperatively until anticoagulant therapy is stopped. Garlic reduces serum levels of cyclosporine and therefore should be avoided in persons taking this drug. 25 Ginger (Zingiber officinale) is used to treat motion sickness, postoperative nausea, and inflammation resulting from arthritis and bronchitis. The mechanism of action is unknown but is thought to be increased gastrointestinal (GI) cell motility, mediated in part through 5-hydroxytryptamine receptor inhibition. Ginger may inhibit platelet aggregation and cause GI upset. 13, 26 It has the potential to interact with antiplatelet therapies and increase the risk of bleeding.
Ginkgo (Ginkgo biloba) is marketed for several uses, including cognitive decline associated with Alzheimer disease, peripheral vascular disease, vertigo, macular degeneration, tinnitus, and erectile dysfunction. Among its effects, ginkgo appears to inhibit plateletactivating factor, and bleeding time may be prolonged when used with cilostazol: several case reports attribute spontaneous intracranial hemorrhage or postoperative bleeding to use of ginkgo. 13, 25 Ginkgo increases the risk of stomach bleeding and should not be used concurrently with nonsteroidal anti-inflammatory drugs (NSAIDs), including cyclooxygenase-2 inhibitors. 18 Ginseng (Panax quinquefolius) is used to prevent the effects of aging, decrease stress, improve energy levels, and treat bleeding disorders, atherosclerosis, appetite loss, memory loss, headaches, and cancer. Ginseng decreases postprandial blood glucose levels and inhibits platelet aggregation, leading to increased coagulation times in animal models. 27 However, ginseng use leading to a decrease in warfarin anticoagulation has been reported. 28 Concerns regarding its use include hypoglycemia in the perioperative period and bleeding.
Milk
29 Side effects are mild and can include stomach upset.
Saw palmetto (Serenoa repens) is commonly used to alleviate urinary dysfunction associated with benign prostatic hyperplasia. Saw palmetto appears to decrease the uptake of testosterone and dihydroxytestosterone. Results from blinded clinical trials suggest that saw palmetto does not significantly decrease symptoms, prostate size, or peak urinary flow compared with placebo, although it causes few side effects. 17, 30, 31 Patients should stop taking saw palmetto at least 2 weeks before surgery because it may increase bleeding time.
Soy is used as a remedy for hypercholesterolemia, hot flashes associated with menopause, memory difficulty, elevated blood pressure measures, several forms of cancer, and osteoporosis. Little evidence exists to support the beneficial role of soy in these conditions, with the exception of a slight decrease in lowdensity lipoprotein associated with its use. 32 The isoflavones in soy are considered to be the active components, but the mechanism of action of soy is unknown.
32 Soy consumption has not been associated with negative side effects other than mild nausea, constipation, and bloating. St. John's wort (Hypericum perforatum) is commonly used to treat mood disorders such as depression. Hypericin and hyperforin are thought to be the active ingredients; hypericin inhibits monoamine oxidase, and hyperforin inhibits the reuptake of serotonin, norepinephrine, dopamine, and γ-aminobutyric acid (GABA). A systematic review of clinical trial data suggests that St. John's wort is effective in the treatment of major depression, with fewer side effects than conventional medicines. 33 Side effects include nausea, headaches, confusion, fatigue, constipation, and photosensitivity. St. John's wort interacts with many other conventional medicines. It increases the metabolism of concomitantly administered drugs by inducing the metabolic liver enzymes CYP3A4 and CYP2C9, 26 thereby reducing the efficacy of antifungal drugs, statins, and calcium channel blockers. St. John's wort may interact with immunosuppressive drugs and can potentially lead to transplant rejection. Finally, it reduces the effectiveness of warfarin. St. John's wort should be stopped at least 1 week before surgery or chemotherapy.
Valerian (Valerian officinalis) is commonly used as a sedative for insomnia. Clinical data on valerian are heterogeneous and suggest that it is of little benefit to insomnia. Valerian is reported to act on GABAergic pathways. Side effects include headache, drowsiness, and cardiac symptoms. 34 One case of cardiac symptoms and delirium following surgery has been reported and attributed to valerian withdrawal, suggesting that valerian may interact with perioperative anesthesia. 26 Valerian should be stopped at least 1 week before surgery to avoid such interaction.
Osteoarthritis
The treatment of painful musculoskeletal disease, in particular, OA, is a large proportion of any orthopaedic surgeon's practice. In this patient population, it is important to consider that conventional medicines prescribed for OA are prone to produce their own set of undesirable side effects. For instance, patients with OA are readily prescribed NSAIDs, which reduce inflammation, pain, and stiffness in arthritic joints. However, side effects can include GI ulcers and bleeding, renal failure, and worsening of the symptoms of preexisting congestive heart failure. An estimated 16,000 deaths annually are related to bleeding of peptic ulcers in patients taking NSAIDs. A large number of CAM supplements are marketed to patients with OA. Because of the high probability of unwanted side effects from conventional medicines, monitoring the use of herbal medicines is critical to the successful management of symptoms and side effects in these patients (Table 3) . Careful history taking and thoughtful prescribing are critical.
Several herbal remedies show some promise in reducing inflammation without the side effects produced by conventional medicines. However, there may be more to the function of these herbs than we are aware of. Figure 1 illustrates the arachidonic acid pathway in inflammation, with the reported activities of herbal medicines highlighted.
Glucosamine sulfate and chondroitin are the most common supplements marketed to those with OA. Glucosamine is an aminosaccharide that is a substrate for the biosynthesis of chondroitin sulfate, hyaluronic acid, and other cartilage molecules. Chondroitin is a constituent of the extracellular matrix, increasing the load-bearing properties of cartilage by increasing its water content. These supplements have been heavily marketed to arthritis pain sufferers. However, the benefit of using these supplements for the treatment of OA is debatable. Several early studies have shown a benefit of using either glucosamine or chondroitin, although these studies were small. 36 A large, 6-month randomized controlled trial sponsored by the National Institutes of Health, the Glucosamine/ chondroitin Arthritis Intervention Trial (GAIT), compared the use of glucosamine, chondroitin, or a combination of the two to celecoxib and placebo in the treatment of knee OA. The trial failed to show significant benefit with respect to pain or joint space width using either supplement alone or in combination. However, a subgroup of patients with moderate to severe pain taking the combination of both glucosamine and chondroitin showed a trend towards a measurable improvement.
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Glucosamine and chondroitin appear to be safe, with mild side effects that include headache, edema, leg pain, and GI upset. However, glucosamine, which is isolated from the exoskeleton of shellfish, has the potential to produce an allergic reaction in sensitive individuals, although this potential is not great because the protein that causes the allergy, tropomyosin, is found only in the muscle of shellfish. Nevertheless, patients with shellfish allergies should consult their physicians before taking glucosamine. Whether glucosamine affects blood glucose levels in patients with type II diabetes is unclear, but caution should be exercised regarding these patients. Glucosamine sulfate does not present concerns for patients with sulfa drug allergies because such allergies involve drugs with sulfonamide groups and not sulfate chemicals (eg, glucosamine, chondroitin). Several case reports have shown that glucosamine increased the international normalized ratio or bruising/bleeding in patients taking warfarin. 38 Chondroitin may cause bleeding in persons with bleeding disorders or in those using blood thinners. Glucosamine and chondroitin should be stopped 2 weeks before surgery and not resumed until anticoagulant therapy is completed.
S-adenosylmethionine (SAM-e) is often used by patients with OA to alleviate pain and to increase function in arthritic joints. It is also marketed as an antidepressant, particularly for patients who do not respond to serotonin reuptake inhibitors. Authors of a recent meta-analysis found that there may be some benefit with its use, although clinical trials to date have been small. 39 Side effects of SAM-e are mild and include headaches, flatulence, nausea, and vomiting; the SAM-e dose should be titrated over 1 to 2 weeks to avoid these side effects. Serotonin syndrome (ie, altered mental and neuromuscular status resulting from high levels of serotonin) can occur when SAM-e is administered concomitantly with prescription antidepressants, including serotonin reuptake inhibitors, tricyclics, and monoamine oxidase inhibitors.
Avocado/soybean unsaponifiables (ASUs), a nutritional supplement heavily marketed to patients with OA, are composed of the oily fractions isolated from the parent compounds after hydrolysis, predominantly phytosterols. In vitro, ASUs demonstrate anti-inflammatory activity, and clinical trials suggest short-term symptomatic but not long-term benefit from its use. 40 Effects of ASU include increased collagen synthesis and inhibition of collagenase as well as reduction of
The arachidonic acid pathway, an important mechanism for producing pain and inflammation. Shown are the reported mechanisms of action of several herbal remedies (orange) and conventional medicines (blue). ASU = avocado/soybean unsaponifiables, COX = cyclooxygenase 40 Side effects are mild and include headache and stomach upset.
Black cohosh (Actaea racemosa, Cimicifuga racemosa) root has traditionally been used as a remedy for menstrual discomfort and the symptoms of menopause. It is also used to relieve inflammation associated with OA and to reduce bone loss in osteoporosis. Black cohosh is thought to have estrogenic effects, but data are conflicting. Preliminary studies suggest that it reduces inflammation and influences markers of bone turnover, but more research is needed. 41 Side effects include GI upset, rash, dizziness, headache, nausea, and vomiting, especially when higher-thanrecommended doses are taken. Critical analysis of several case reports of hepatotoxicity associated with black cohosh uncovered confounding variables, thus preventing the establishment of a causal relationship. 42 Further study is required. Boswellia serrata (ie, frankincense, salai guggal) is an ayurvedic remedy used to treat arthritis and musculoskeletal pain. It has been shown to have anti-inflammatory properties, and clinical trials have demonstrated that it is effective in the treatment of OA pain, although these trials had small sample sizes. 43 Boswellia is well tolerated; side effects include nausea and diarrhea.
Bromelain is a sulfhydryl proteolytic enzyme extract of pineapple used to débride burn wounds and as an anti-inflammation remedy for OA. Its anti-inflammatory properties result from the reduction of prostaglandin E 2 and thromboxane A 2 , and inhibition of bradykinin by depletion of in kallikrein system. 44 To date, however, research results are unconvincing. A small double-blind placebo-controlled study did not find bromelain to be effective in relieving symptoms or enhancing quality of life in patients with diagnosed knee OA. 40, 45 Bromelain is an antithrombotic, and it may cause bleeding if used in conjunction with warfarin and enoxaparin by increasing the activity of these drugs. Patients should stop taking bromelain 2 weeks before surgery. If postoperative anticoagulant therapy is necessary, bromelain should not be taken until anticoagulant therapy has been stopped. Bromelain is metabolized by and inhibits the enzyme CYP2C9; thus, it may decrease the metabolism of its substrates (eg, tetracycline).
Cat's claw (Uncaria tomentosa, U guianensis) is used to enhance immunity and as an anti-inflammatory to treat OA. Several studies suggest its use is beneficial, alone or in combination, in the treatment of OA; however, these studies were small, and further research is required. 40, 46 Cat's claw is generally regarded as safe, although its use should be avoided by pregnant women. Side effects include hypotension and GI symptoms. Cat's claw also could have an additive effect when taken with hypotensive or anticoagulant medications. It inhibits CYP3A4 and should not be taken with its substrates (eg, cyclosporine, some benzodiazepines).
Flavocoxid is a prescription medical food isolated from Chinese scullcap (Scutellaria baicalensis) and Acacia catechu bark. Flavocoxid is used to treat OA and is thought to inhibit cyclooxygenase and 5-lipoxygenase eznymes. 47 One study has shown that flavocoxid significantly reduces knee OA (P ≤ 0.001) and is safe. 48 Because of its purported mechanism of action, its use should be avoided in those with ulcers or GI bleeding. Side effects are mild and include nausea.
Thunder god vine (Tripterygium wilfordii) is a Chinese herb used to treat inflammation and conditions involving overactivity of the immune system. It is marketed as an oral and/or topical remedy for rheumatoid arthritis. 
Summary
Orthopaedic use of CAM is evolving. Lack of safety and efficacy data for herbal remedies is compounded by the lack of communication regarding their use by patients and physicians. Although the use of herbal medicines should be monitored by the patient's primary care physician to prevent or treat possible drug-herb interactions or side effects, orthopaedic surgeons must have an understanding of the most common remedies used by their patients. This knowledge may help in counseling patients about the possible interactions between conventional medicines and herbal supplements. In addition, providing instructions to help patients stop taking herbal supplements perioperatively may lead to reduced postoperative blood loss, thereby decreasing the incidence of hematoma formation, infection, and need for transfusion. Specific questionnaires to elicit such information from patients, particularly in the presurgical interview, should be developed. 
